Invivyd to Host Conference Call Discussing Second Quarter 2024 Financial Results and Business Highlights
Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company focused on protecting against serious viral infectious diseases, has announced a conference call scheduled for Wednesday, August 14, 2024, at 8:30 a.m. ET. The call will cover the company's financial results for the second quarter ended June 30, 2024, along with recent business highlights. Interested parties can register for the webcast through a provided link, while analysts who wish to participate in the Q&A session have a separate link available. A replay of the webcast will be accessible on Invivyd's investor website approximately two hours after the call concludes. Participants are advised to join 15 minutes before the start time.
Invivyd, Inc. (Nasdaq: IVVD), una società biofarmaceutica focalizzata sulla protezione contro gravi malattie infettive virali, ha annunciato una conferenza telefonica programmata per mercoledì 14 agosto 2024, alle 8:30 ora orientale. La chiamata tratterà i risultati finanziari dell'azienda per il secondo trimestre chiuso il 30 giugno 2024, insieme ai recenti evidenti risultati aziendali. Le parti interessate possono registrarsi per la trasmissione web attraverso un link fornito, mentre gli analisti che desiderano partecipare alla sessione di domande e risposte hanno un link separato a disposizione. Una registrazione della trasmissione web sarà accessibile sul sito web degli investitori di Invivyd circa due ore dopo la conclusione della chiamata. I partecipanti sono invitati a unirsi 15 minuti prima dell'orario di inizio.
Invivyd, Inc. (Nasdaq: IVVD), una empresa biofarmacéutica centrada en la protección contra enfermedades infecciosas virales graves, ha anunciado una conferencia telefónica programada para miércoles 14 de agosto de 2024, a las 8:30 a.m. ET. La llamada cubrirá los resultados financieros de la empresa correspondientes al segundo trimestre que finalizó el 30 de junio de 2024, junto con los recientes aspectos destacados del negocio. Las partes interesadas pueden registrarse para la transmisión web a través de un enlace proporcionado, mientras que los analistas que deseen participar en la sesión de preguntas y respuestas tienen un enlace separado disponible. Una repetición de la transmisión web será accesible en el sitio web de inversores de Invivyd aproximadamente dos horas después de que finalice la llamada. Se recomienda a los participantes unirse 15 minutos antes de la hora de inicio.
Invivyd, Inc. (Nasdaq: IVVD)는 심각한 바이러스 감염병으로부터 보호하는 데 중점을 둔 생명공학 회사로, 2024년 8월 14일 수요일 오전 8시 30분 동부 표준시에 예정된 컨퍼런스 콜을 발표했습니다. 이 전화 통화에서는 2024년 6월 30일 종료된 두 번째 분기 재무 결과와 최근 사업 하이라이트에 대해 다룰 것입니다. 관심 있는 개인은 제공된 링크를 통해 웹캐스트에 등록할 수 있으며, Q&A 세션에 참여하고자 하는 분석가는 별도의 링크를 통해 참여할 수 있습니다. 웹캐스트의 재생은 통화 종료 후 약 두 시간 후에 Invivyd의 투자자 웹사이트에서 접근할 수 있습니다. 참가자는 시작 시간 15분 전에 접속하는 것이 좋습니다.
Invivyd, Inc. (Nasdaq: IVVD), une société biopharmaceutique axée sur la protection contre les maladies infectieuses virales graves, a annoncé une conférence téléphonique prévue pour mercredi 14 août 2024 à 8h30 H.E.. Cet appel portera sur les résultats financiers de l'entreprise pour le deuxième trimestre clos le 30 juin 2024, ainsi que sur les faits marquants récents de l'entreprise. Les parties intéressées peuvent s'inscrire à la webdiffusion via un lien fourni, tandis que les analystes souhaitant participer à la session de questions-réponses disposent d'un lien distinct. Un replay de la webdiffusion sera accessible sur le site des investisseurs d'Invivyd environ deux heures après la fin de l'appel. Les participants sont invités à se connecter 15 minutes avant l'heure de début.
Invivyd, Inc. (Nasdaq: IVVD), ein biopharmazeutisches Unternehmen, das sich auf den Schutz vor schweren viralen Infektionskrankheiten konzentriert, hat einen Konferenzanruf für Mittwoch, den 14. August 2024, um 8:30 Uhr ET angekündigt. In dem Anruf werden die finanziellen Ergebnisse des Unternehmens für das im 30. Juni 2024 endende zweite Quartal sowie aktuelle Geschäftshighlights behandelt. Interessierte Parteien können sich über einen bereitgestellten Link für das Webcast registrieren, während Analysten, die an der Q&A-Session teilnehmen möchten, über einen separaten Link Zugang haben. Eine Aufzeichnung des Webcasts wird etwa zwei Stunden nach Abschluss des Anrufs auf der Investoren-Website von Invivyd verfügbar sein. Teilnehmer werden gebeten, 15 Minuten vor Beginn der Sitzung beizutreten.
- None.
- None.
WALTHAM, Mass., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will host a conference call on Wednesday, August 14, 2024, at 8:30 a.m. ET to discuss its financial results for the second quarter ended June 30, 2024, and recent business highlights.
Listeners can register for the webcast via this link. Analysts wishing to participate in the question and answer session should use this link. A replay of the webcast will be available via the company’s investor website approximately two hours after the call’s conclusion. Those who plan on participating are advised to join 15 minutes prior to the start time.
About Invivyd
Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
Contacts:
Media Relations
(781) 208-1747
media@invivyd.com
Investor Relations
(781) 208-1747
investors@invivyd.com
FAQ
When is Invivyd (IVVD) hosting its Q2 2024 earnings call?
What period will Invivyd's (IVVD) financial results cover in the upcoming call?
How can investors access Invivyd's (IVVD) Q2 2024 earnings call?
Will there be a replay available for Invivyd's (IVVD) Q2 2024 earnings call?
